Page last updated: 2024-08-24

cidofovir anhydrous and Immunoblastic Large-Cell Lymphoma

cidofovir anhydrous has been researched along with Immunoblastic Large-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agbalika, F; Boulanger, E; Daniel, MT; Grollet, L; Maarek, O; Molina, JM; Oksenhendler, E; Sigaux, F1

Reviews

1 review(s) available for cidofovir anhydrous and Immunoblastic Large-Cell Lymphoma

ArticleYear
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
    The hematology journal : the official journal of the European Haematology Association, 2001, Volume: 2, Issue:3

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Chromosome Aberrations; Cidofovir; Cyclophosphamide; Cytosine; Doxorubicin; Drug Therapy, Combination; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunophenotyping; Interferon-alpha; Karyotyping; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prednisone; Prognosis; Remission Induction; Survival Analysis; Vincristine; Vindesine; Viral Load

2001